The Children's Oncology Group meeting was March 27 - 30 in Minneapolis. Presentations were given by Jinu on new targeted therapies for undifferentiated sarcomas, and an update of the DIPG preclinical consortium was given by Charles.
The AACR meeting is now in progress, and beginning yesterday with the session on Modeling Pediatric Malignancy where Charles presented, "integrative biology of rhabdomysarcoma
using genetic murine models" and attended the Pediatric Preclinical Testing Program working meeting. The Pediatric Cancer Town Hall meeting is tonight.
A key new presentation from the Raabe lab is tomorrow, "High-level activation of the Notch pathway in diffuse intrinsic pontine glioma" by Hutt et al (A Johns Hopkins - NCI consortium). Also presented by Dr. Ian Pollack are the promising early results of a DIPG vaccine trial (caveats not withstanding).